EU approves Sanofi diabetes drug; Novian and NanoViricides report new venture rounds; Academics cite success in Alzheimer's animal study;

 @FierceBiotech: Popular this weekend: Merck R&D calls for a time-out on osteo blockbuster hopeful. Story | Follow @FierceBiotech

@JohnCFierce: Interesting to see Medicines Co. pay Alnylam $25M upfront for early-stage PCSK9 program. More | Follow @JohnCFierce

@RyanMFierce: Gilead says SVR 67% in oral combo is same as SVR on interferon group in Ph3 FISSION study in hep C types 2&3, meets primary endpoint. Release | Follow @RyanMFierce

> Sanofi ($SNY) says that the EU has approved its diabetes drug Lyxumia. Report

> Chicago-based Novian Health has raised $11 million in a Series A designed to advance its work on a laser treatment for breast cancer. Release

> NanoViricides says it has raised $6 million from unnamed investors backing their first clinical study of their experimental flu drug. Release

Pharma News

@FiercePharma: U.S. government finally gets payment rule published. News | Follow @FiercePharma

@EricPFierce: AstraZeneca, Bristol-Myers Squibb create 'Diabetes Inc.,' to give complete attention to diabetes treatment sales. More | Follow @EricPFierce

@AlisonBFierce: A study of the first new TB vaccine in 90 years showed it offered no added benefit to the current vaccine. News | Follow @AlisonBFierce

> Exports to U.S. to power Indian drugmaker growth. Item

> Feds grab Shire's attention on Adderall marketing. Report

> Loss of Actos weighs heavily on Takeda. News

Medical Device News

 @FierceMedDev: Swiss team: Nanoscale tissue check boosts breast cancer Dx. More | Follow @FierceMedDev

 @MarkHFierce: GE and the N.F.L. will jointly develop new imaging tech to spot concussions. News| Follow @MarkHFierce

 @DamianFierce: Icon is spending $52M on Cross Country Healthcare's clinical trials business. Report | Follow @DamianFierce

> AdvaMed targets Puerto Rico device tax hike as unfair burden. News

> Covidien ticks toward pharma spinoff. Article

> Yogurt, pacemakers compel conflict-of-interest issues in Florida. Item

CRO News

> Parexel brightens 2013 outlook after strong quarter. Story

> BioClinica eyed for $123M buyout, eventual merger. News

> Indian clinical trials: Private group steps in to increase transparency. More

> Patheon brings bioavailability service to EU with plant expansion. Report

Biotech IT News

> Cypher Genomics chief speaks out from DNA data-crunching crowd. Story

> Clinical trials software player agrees to $123M buyout. News

> Boehringer unleashes iPhone app amid COPD blitz. Report

> Biopharma targets bioinformatics aces in R&D overhaul. Article

And Finally… Academic investigators in the U.K. say that an experimental therapy erased a third of the toxic plaque often associated with Alzheimer's disease in an animal study. Story

 

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.